Abstract:Background Advanced stage osteoradionecrosis (ORN) and medication-related osteonecrosis of the jaw (MRONJ) are challenging disease entities requiring multimodal therapy including surgical resection. However, risk factors associated with infection recurrence are poorly understood. Purpose The purpose of this study was to identify risk factors associated with infection recurrence following resection of advanced stage ORN or MRONJ of the mandible. Study design, setting, sample This was a retrospective cohort study including patients who underwent segmental mandibulectomy for management of ORN or MRONJ between 2016 and 2021 at the authors' institution. Subjects who did not have margin viability data were excluded. Predictor/exposure/independent variable The primary predictor variable was viability of resection margins on histopathologic analysis (viable or non-viable). Secondarily, other risk factors categorized as demographic (age, sex, race), medical (comorbidities), and perioperative (reconstructive modality, antibiotic duration, microbiological growth) were evaluated. Main outcome variable The primary outcome variable was time to infection recurrence defined as time from surgical resection to clinical diagnosis of a fistula tract, abscess, or persistent inflammatory symptoms necessitating surgical intervention. Covariates Not applicable. Analyses Descriptive and bivariate statistics were used to identify associations between risk factors and time to infection recurrence. A significance level of p ≤ 0.05 was considered significant. Results The cohort consisted of 57 subjects with a mean age of 63.3 ± 10.0 years (71.9% Male, 75.4% White) treated for ORN (47.4%) or MRONJ (52.6%). A total of 19/57 (33%) subjects developed a recurrence of infection with one and two year survival of 75.8% and 66.2%, respectively. Non-viable resection margins were associated with earlier time to infection recurrence (p ≤ 0.001, Hazard Ratio (HR) = 11.9, 95% Confidence Interval (CI) = 3.84 – 36.7) as was younger age (p = 0.005, HR = 0.921, 95% CI = 0.869 – 0.976) and atypical pathogen growth on culture (p = 0.002, HR = 8.58, 95% CI = 2.24 – 32.8). Conclusions and Relevance Histopathologic margin viability was associated with earlier time to infection recurrence following resection of advanced stage ORN or MRONJ of the mandible. Additional studies are needed to identify interventions that may improve outcomes in this demographic.

Microvascular reconstruction of medication related osteonecrosis of the head and neck

Microvascular reconstruction of midface osteoradionecrosis

Surgical Treatment of Severe Medication-Related Osteonecrosis of the Jaw.

Antiresorptive agents enhance ossification of free flap reconstructions of the mandible: a radiological retrospective cohort study

Fibular flap mandibular reconstruction for third-stage medication-related osteonecrosis of the jaw: A retrospective single-center study

Treatment Challenges in Soft Tissue Reconstruction in Patients With MRONJ - The Nasolabial Flap

Microsurgical Reconstruction after Bisphosphonate-Related Osteonecrosis of the Jaw: Our Experience with Fibula Free Flap

The adjunctive use of Leukocyte-Platelet Rich Fibrin (L-PRF) in the management of Medication Related Osteonecrosis of the Jaw (MRONJ): a retrospective observational study

Medication-Related Osteonecrosis of the Jaw: A Systematic Review of Case Reports and Case Series

Innovative Use of Limberg Flap for MRONJ Reconstruction

Comparing the Outcomes of Osteocutaneous Radial Forearm and Fibula Free Flaps in the Reconstruction of Mandibular Osteoradionecrosis

Risk Factors for Infection Recurrence After Surgical Resection of Advanced Stage Osteonecrosis of the Mandible

Medication Related Osteonecrosis of the Jaw (MRONJ) Systemic Review: Mevalonate Pathway Mechanisms Explored

Treatment of medication-related osteonecrosis of the jaw with cell therapy

Medial Femoral Condyle Periosteal Free Flap for Bone Coverage Following Debridement of Intermediate-Stage Osteoradionecrosis of the Jaw

Free buccal fat pad graft for the bone defect filling of medication-related osteonecrosis of the jaws: A novel surgical approach

Debridement using Piezosurgical Device and Incorporation of Autologous Platelet-Rich Fibrin in Management of Stage III Medication-Related Osteonecrosis of the Jaw — A Case study and Review of Literature

Oromandibular Reconstruction Using Microvascularized Bone Flap: Report of 1038 Cases from a Single Institution.

An institutional protocol including socket alveoplasty and primary closure following dental extractions for patients with an elevated risk of developing medication-related osteonecrosis of the jaw

Improvement of Quality of Life after Surgical Treatment of Patients with MRONJ: A Prospective Analysis Using the SF-12 and OHIP-14 Questionnaires

Nutritional Status in Patients with Medication-Related Osteonecrosis of the Jaw (MRONJ)